Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies

NCT00536978 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma
Leukemia

Interventions

DRUG: ARA-C
DRUG: BCNU
DRUG: Campath-1H
DRUG: Cyclophosphamide
DRUG: Etoposide
DRUG: Fludarabine
DRUG: Melphalan
DRUG: Rituximab
OTHER: Allogeneic Stem Cell Transplantation
RADIATION: Total body radiation (TBI)
DRUG: Methotrexate
DRUG: Tacrolimus
PROCEDURE: Adback NK or T Cell

Sponsor

M.D. Anderson Cancer Center